Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Breath of life: exhaled gas may reveal ICU outcomes

NCT ID NCT07454057

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will measure exhaled carbon monoxide daily in 220 ICU patients to see if changes in this gas are linked to survival and recovery. It is purely observational, meaning no treatment is given. The goal is to learn whether this simple breath test can help doctors predict complications like kidney injury or longer hospital stays.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 220 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult intensive care unit (ICU) patients (≥18 years) admitted to the study site will be screened consecutively. Eligible participants are those expected to remain in the ICU for at least 48 hours and able to complete daily exhaled carbon monoxide (eCO) measurements (spontaneously breathing or mechanically ventilated). Written informed consent will be obtained from the patient or a legally authorized representative. Patients meeting any exclusion criteria (e.g., carbon monoxide poisoning, active smoking within 24 hours, inability to perform breath sampling, pregnancy/breastfeeding, hereditary hemoglobinopathies) will not be enrolled. Participants may be withdrawn if informed consent is revoked, if continued data collection is judged clinically inappropriate, if the patient is transferred and lost to follow-up, or if eCO data are missing for more than 50% of the 7-day collection period (fewer than 4 valid measurements).

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥ 18 years 2. Admitted to the intensive care unit (ICU) at the study site 3. Expected ICU length of stay ≥ 48 hours 4. Able to complete exhaled carbon monoxide (eCO) measurement (spontaneously breathing or mechanically ventilated) 5. Written informed consent provided by the patient or a legally authorized representative Exclusion Criteria: 1. Carbon monoxide poisoning 2. Active smoking within 24 hours prior to ICU admission 3. Unable to perform breath sampling (e.g., massive airway bleeding, severe airway obstruction, extracorporeal membrane oxygenation) 4. Ineffective sampling due to poor mask seal or special ventilation modes 5. Pregnant or breastfeeding 6. Known hereditary hemoglobinopathies (e.g., sickle cell disease, thalassemia) 7. Patient or family refusal 8. Other conditions deemed unsuitable by investigators

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critical illness; intensive care unit patients are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.